Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease
Beta thalassaemia major (TM), a potentially fatal haemoglobinopathy, has transformed from a fatal to a chronic disease in the last 30 years following the introduction of effective, personalised iron chelation protocols, in particular the use of oral deferiprone, which is most effective in the remova...
Main Authors: | Annita Kolnagou, Marios Kleanthous, George J. Kontoghiorghes |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-07-01
|
Series: | Frontiers in Bioscience-Elite |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBE/14/3/10.31083/j.fbe1403018 |
Similar Items
-
Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology
by: Christina N. Kontoghiorghe, et al.
Published: (2015-11-01) -
Influence of blood transfusion rate on some clinical manifestations in β-thalassaemia major patients
by: Khalid Mahdi Salih, et al.
Published: (2016-04-01) -
The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases
by: George J. Kontoghiorghes
Published: (2023-07-01) -
The Outcomes of Patients with Haemoglobin Disorders in Cyprus: A Joined Report of the Thalassaemia International Federation and the Nicosia and Paphos Thalassaemia Centres (State Health Services Organisation)
by: Michael Angastiniotis, et al.
Published: (2022-11-01) -
Polypharmacotherapy in Psychiatry: Global Insights from a Rapid Online Survey of Psychiatrists
by: Michal Ordak, et al.
Published: (2022-04-01)